drugset / Trial / NCT02988024
Pilot BA Study of New LY03005 vs Pristiq
RandomizedParallel-groupOpen-labelTreatment
Summary
The objects of this study is to assess the relative bioavailability (BA) of 80 mg LY03005 oral tablets compared to 50 mg Pristiq® oral tablets after a single oral intake under fasting conditions in healthy subjects between 18 and 50 years of age.
Timeline
- Start
- 2016-12-07
- Primary completion
- 2016-12-28
- Completion
- 2016-12-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Desvenlafaxine | Other / unclassified | 50 mg | Oral |
| Subject | Toludesvenlafaxine | Small molecule | 80 mg | Oral |